CELA, ENEIDA
 Distribuzione geografica
Continente #
AS - Asia 54
NA - Nord America 51
EU - Europa 39
SA - Sud America 10
Totale 154
Nazione #
US - Stati Uniti d'America 49
SG - Singapore 30
IT - Italia 18
HK - Hong Kong 11
BR - Brasile 9
CN - Cina 6
GB - Regno Unito 6
VN - Vietnam 4
FI - Finlandia 3
NL - Olanda 3
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
DE - Germania 1
ES - Italia 1
FR - Francia 1
HN - Honduras 1
IN - India 1
RO - Romania 1
RU - Federazione Russa 1
SE - Svezia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 154
Città #
Hong Kong 11
Singapore 10
Beijing 5
New York 5
Ashburn 4
Los Angeles 4
Del Norte 3
Ho Chi Minh City 3
Buffalo 2
Chieti 2
Council Bluffs 2
Engelhard 2
Florence 2
Helsinki 2
Monte Porzio Catone 2
Perugia 2
Amsterdam 1
Baku 1
Campo Grande 1
Chicago 1
Cleveland 1
Dallas 1
Denver 1
Dubai 1
Duson 1
Fortaleza 1
Hanoi 1
Itápolis 1
Juquiá 1
Lancaster 1
Lappeenranta 1
London 1
Lucknow 1
Manassas 1
Milan 1
Naples 1
Nuremberg 1
Paramaribo 1
Poplar 1
Port of Spain 1
Porto Velho 1
Redondo Beach 1
Ribeirão Preto 1
Rio de Janeiro 1
Santa Clara 1
Santa Izabel do Oeste 1
St. George 1
Stockholm 1
São Paulo 1
Tegucigalpa 1
Warsaw 1
Zachary 1
Totale 97
Nome #
Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review 52
Kinesiophobia as part of the psychological burden in Spondyloarthritis: a case-control study 52
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity 49
Modulation of cellular senescence in psoriatic arthritis: exploring the potential impact of bDMARDs on telomere length, mtDNA copy number, and oxidative damage 13
Totale 166
Categoria #
all - tutte 693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 693


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 0 0 7 0 0 1
2024/202568 1 8 4 13 0 4 5 1 4 2 16 10
2025/202690 12 11 10 21 31 5 0 0 0 0 0 0
Totale 166